Motley Fool Staff

One Foolish listener wants to know about the business model for this exciting part of the video game and entertainment industries.

One Foolish listener wants to know whether law firms' investigations of the company should be a genuine concern for investors.

The promise of cellular therapies in cancer treatment could allow Gilead Sciences to become a top-tier player in oncology.

Gilead Sciences is paying $11.9 billion in cold, hard cash to acquire CAR-T drug developer Kite Pharma.

Terry Turner doesn’t just pay lip service to the culture at Pinnacle Financial Partners. He’s leveraged it to produce some of the bank industry’s best returns.

Jamie Dimon has big shoes to fill at the top of the nation’s biggest bank.

A focus on efficiency and prudent underwriting made the U.S. Bancorp CEO one of the industry’s leading executives.

The former CEO of Bank of America was behind the movement to open up nationwide branch banking.

Few bankers exhibit the qualities that have made Warren Buffett successful as well as Robert Wilmers does.

It seemed like a good idea at the time! What we learned from Devon Energy’s years-long underperformance.

There are right ways and wrong ways to react to mistakes.

After postulating in 2015 that a burgeoning sales scandal at Wells Fargo wouldn’t amount to anything, we look at the lessons learned from being wrong.

On a November 2015 show, we predicted that Wells Fargo’s burgeoning sales scandal would amount to much ado about nothing.

OPKO Health’s been dealt setbacks that have caused its shares to nose-dive, rather than head higher. Is that about to change?

Regulators didn’t end up approving Walgreens' acquisition of Rite Aid. Will they deny the two companies' latest agreement, too?

A lot of tech companies lean on adjusted numbers that they feel “better reflect” what’s going on with their businesses. That’s not always what investors should follow.

Though they may get all of the attention and huge initial gains, what happens down the road is usually less pretty.

More and more companies in this sector are issuing shares with diluted voting rights -- or none at all.

By the time many investors discover a company, the stock may seem as if it’s already too high.

The digital revolution has brought technology to every business, so where should investors draw the border around this industry?